AlenCiken
Long

In-Line Q4 EPS Analyst Sees Better 2nd-Half

NYSE:CSLT   CASTLIGHT HEALTH INC
Castlight Health (NYSE: CSLT) reported Q4 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $42.1 million versus the consensus estimate of $40.47 million.

GUIDANCE:

Castlight Health sees FY2019 EPS of $0.00-$0.03, versus the consensus of $0.01. Castlight Health sees FY2019 revenue of $153-158 million, versus the consensus of $159.77 million.

https://www.barchart.com/story/stocks/qu...

https://www.fool.com/investing/2019/03/0...

EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
SV Svenska
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
AR العربية
HE עברית
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Get Help Feature Request Blog & News FAQ Wiki Twitter
Profile Profile Settings Account and Billing Get Help Ideas Published Followers Following Private Messages Chat Sign Out